These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11155102)

  • 1. Re: A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):760-1. PubMed ID: 11155102
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone mineral density in Turner's syndrome--a longitudinal study.
    Shaw NJ; Rehan VK; Husain S; Marshall T; Smith CS
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):367-70. PubMed ID: 9373461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
    Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
    Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy.
    Lanes R; Gunczler P; Paoli M; Weisinger JR
    Horm Res; 1995; 44(4):168-71. PubMed ID: 8522278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on growth hormone therapy for Turner's syndrome.
    Rosenfeld RG
    Acta Paediatr Scand Suppl; 1989; 356():103-8; discussion 109-10. PubMed ID: 2683569
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies.
    Suganuma N; Furuhashi M; Hirooka T; Moriwaki T; Hasegawa Y; Mori O; Ogawa M
    Endocr J; 2003 Jun; 50(3):263-9. PubMed ID: 12940454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in Turner's syndrome and the influence of pubertal development.
    Nadeem M; Roche EF
    Acta Paediatr; 2014 Jan; 103(1):e38-42. PubMed ID: 24354573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in speaking fundamental frequency in hormone-treated patients with Turner's syndrome--a longitudinal study of four cases.
    Andersson-Wallgren G; Albertsson-Wikland K
    Acta Paediatr; 1994 Apr; 83(4):452-5. PubMed ID: 8025411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
    Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
    Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls With Turner Syndrome.
    Soucek O; Schönau E; Lebl J; Willnecker J; Hlavka Z; Sumnik Z
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1188-1197. PubMed ID: 29300907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
    Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current views on the treatment of Turner's syndrome.
    Milner RD
    Acta Paediatr Scand Suppl; 1987; 331():53-8. PubMed ID: 3300156
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome.
    Nilsson KO
    Acta Paediatr Scand Suppl; 1989; 362():61-8. PubMed ID: 2485602
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages.
    Soucek O; Lebl J; Snajderova M; Kolouskova S; Rocek M; Hlavka Z; Cinek O; Rittweger J; Sumnik Z
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):445-52. PubMed ID: 21138463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of hormonal treatment on bone mineralization in Turner syndrome].
    Saggese G; Cinquanta L; Bertelloni S
    Arch Pediatr; 1998; 5 Suppl 4():371S-374S. PubMed ID: 9853086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.